References:

［1］COLLABORATORS GBDMD.Global,regional,and national burden of 12 mental disorders in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019［J］.Lancet Psychiatry,2022,9(2):137-150.
［2］HUANG Y,WANG Y,WANG H,et al.Prevalence of mental disorders in China:a cross-sectional epidemiological study［J］.The Lancet Psychiatry,2019,6(3):211-224.
［3］VAN DEN NOORT M,YEO S,LIM S,et al.Acupuncture as Add-On Treatment of the Positive,Negative,and Cognitive Symptoms of Patients with Schizophrenia:A Systematic Review［J］.Medicines(Basel,Switzerland),2018,5(2):29.
［4］刘敬萱,孙彦辉,张莘,等.耳针理论学说的研究现状与思考［J］.针刺研究,2021,46(10):893-900.
［5］王红,刘晓茹,姜劲峰,等.耳皮内刺治疗抑郁症的临床观察［J］.中国中医基础医学杂志,2020,26(4):526-528.
［6］ZHANG R,LU S,MENG L,et al.Genetic evidence for the association between the early growth response 3(EGR3)gene and schizophrenia［J］.PLoS One,2012,7(1):e30237.
［7］YAMADA K,GERBER DJ,IWAYAMA Y,et al.Genetic analysis of the calcineurin pathway identifies members of the EGR gene family,specifically EGR3,as potential susceptibility candidates in schizophrenia［J］.Proc Natl Acad Sci U S A,2007,104(8):2815-2820.
［8］KIM SH,SONG JY,JOO EJ,et al.EGR3 as a potential susceptibility gene for schizophrenia in Korea［J］.Am J Med Genet B Neuropsychiatr Genet,2010,153b(7):1355-1360.
［9］HUENTELMAN MJ,MUPPANA L,CORNEVEAUX JJ,et al.Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk［J］.PLoS One,2015,10(10):e0135076.
［10］GALLITANO-MENDEL A,WOZNIAK DF,PEHEK EA,et al.Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects［J］.Neuropsychopharmacology,2008,33(6):1266-1275.
［11］SONG T,NIE B,MA E,et al.Functional magnetic resonance imaging reveals abnormal brain connectivity in EGR3 gene transfected rat model of schizophrenia［J］.Biochem Biophys Res Commun,2015,460(3):678-683.
［12］XIAO X,XU X,LI F,et al.Anti-inflammatory treatment with beta-asarone improves impairments in social interaction and cognition in MK-801 treated mice［J］.Brain Res Bull,2019,150:150-159.
［13］WANG X,LUO C,MAO XY,et al.Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats［J］.Brain Res,2019,1719:30-39.
［14］JEONG Y,BAE HJ,PARK K,et al.4-Methoxycinnamic acid attenuates schizophrenia-like behaviors induced by MK-801 in mice［J］.Journal of Ethnopharmacology,2022,285:114864.
［15］STEPNICKI P,KONDEJ M,KACZOR AA.Current Concepts and Treatments of Schizophrenia［J］.Molecules,2018,23(8).
［16］钟琴,田真真,晏敏.中医药治疗精神分裂症的研究进展［J］.江西中医药,2022,53(6):67-69.
［17］林琴韵,杨朝阳.中医药治疗精神分裂症研究进展［J］.河南中医,2022,42(9):1429-1434.
［18］周林艳,刘文娟.中医情志护理和耳穴压豆对精神分裂症患者认知功能和社会功能的影响［J］.新中医,2020,52(14):144-146.
［19］宋欣欣,安琦,李玉焕.针灸治疗精神分裂症的研究进展［J］.双足与保健,2019,28(3):25-26.
［20］宁式颖,郑璐,李响,等.针灸治疗精神分裂症取穴规律研究［J］.中医药信息,2015,32(2):31-34.
［21］黄庆元,李建国.耳针治疗精神分裂症幻听34例［J］.甘肃中医学院学报,2005,22(1):36-38.
［22］王美娜,张永臣,王家振,等.项七针联合耳穴贴压治疗首发精神分裂症32例［J］.中国针灸,2022,42(3):355-356.
［23］杨杰,张晓明,马新英,等.耳穴压豆联合奥氮平治疗精神分裂症的临床研究［J］.陕西中医,2015,36(7):829-830.
［24］戴铁城.以耳压法为主治疗青春型精神分裂症［J］.甘肃中医,1994,7(4):25.
［25］HILZ MJ.Transcutaneous vagus nerve stimulation - A brief introduction and overview［J］.Auton Neurosci,2022,243:103038.
［26］WANG L,WANG Y,WANG Y,et al.Transcutaneous auricular vagus nerve stimulators:a review of past,present,and future devices［J］.Expert Review of Medical Devices,2022:1-19.
［27］BUTT MF,ALBUSODA A,FARMER AD,et al.The anatomical basis for transcutaneous auricular vagus nerve stimulation［J］.J Anat,2020,236(4):588-611.
［28］LIU CH,YANG MH,ZHANG GZ,et al.Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression［J］.Journal of neuroinflammation,2020,17(1):54.
［29］YU Y,HE X,WANG Y,et al.Transcutaneous auricular vagal nerve stimulation inhibits limbic-regional P2X7R expression and reverses depressive-like behaviors in Zucker diabetic fatty rats［J］.Neurosci Lett,2022,775:136562.
［30］PEREZ SM,CARRENO FR,FRAZER A,et al.Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia［J］.J Neurosci,2014,34(28):9261-9267.